Investment Trust Centre
HomeDechra Pharmaceuticals revenue growth slows to 14% CER as Covid impact unwindsDechra-Pharmaceuticals-11072022

Dechra-Pharmaceuticals-11072022

Cat,And,Vet

Most Read

Get in Touch

Legals

My account

Latest Stories

Shares

Tullow Oil wins tax case

Shares

AIM movers: Volex acquisition beats target and Revolution Beauty continues recovery

Premium

Share Tip: Against a background of bumper cinema slates and ahead of its Trading Update, the shares of the Everyman Media Group, now 52.50p...

Shares

AIM movers: Revolution Beauty settlement and potential Nasdaq merger for Poolbeg Pharma

Commodities/FX

Building a Weekly Trading Routine Around Your Forex Calendar

© UK Investor Group UK Investor and UK Investor Magazine are registered trademarks of UK Investor Group Ltd (09932115) | All rights reserved